WAVE Life Sciences Appoints Keith Regnante as Chief Financial Officer
Go back to WAVE Life Sciences Appoints Keith Regnante as Chief Financial Officer| (NASDAQ: WVE) | Delayed: 4.90 -0.14 (2.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.04 | 52 Week High | $38.50 | |||
| Open | $5.06 | 52 Week Low | $8.95 | |||
| Day High | $5.07 | P/E | N/A | |||
| Day Low | $4.84 | EPS | $0.00 | |||
| Volume | 3,811,665 | |||||

